The Connecticut Business & Industry Association is the voice of business in Connecticut, with thousands of member companies championing change at the State Capitol, shaping debate about economic competitiveness, and fighting for a better future for all.
The Connecticut Bioscience Growth Council consists of representatives from CBIA member companies with biotech, pharmaceutical, and bioscience-related interests.
It was organized to better address the issues affecting this growing sector, especially the importance of strong intellectual property protection and the industry's uniquely high R&D costs.
Working with CBIA staff, the council communicates to policymakers strategies to fuel industry job growth and timely introduction of new medicines, medical devices, and products developed and/or manufactured with the aid of bioscience.
The council will represent the interests of biotech and biopharma companies—large and small—at the State Capitol and regulatory agencies, providing greater advocacy support and resources, and developing an overall plan for better positioning these companies at the state, regional, and national level.
Council members meet regularly and interacts with the Connecticut General Assembly's Life Sciences Caucus and Connecticut's Congressional delegation.
The council is led by CBIA's Paul Pescatello.
As part of the council's advocacy efforts, Pescatello works to enhance and secure important policies, such as the research and development tax credit for both established and early-stage companies.
In addition to representing the biotech and biopharma industries at the state level, Pescatello serves as president of the New England Biotech Association, chairs We Work for Health Connecticut, and works closely with the Biotechnology Industry Organization.
Vaccines—the harnessing of the body's own immune system to ward off disease—are an important public health achievement. They have eradicated...
Connecticut's capital base tax, essentially a tax on corporate savings accounts, has never made much sense, but in today's economy...
Connecticut's largest business organization released its 2020 policy priorities today, calling for state lawmakers to make job and economic growth...
Due diligence is the term business people use to describe the steps they take to evaluate a deal—do the pros...
Connecticut jumped three places to fourth among all states in Bloomberg's latest U.S. State Innovation Index. The finance and business...
In the world of economic development, biotech is the crown jewel. It brings new medicines and medical devices that save...